This is not an unbroken ground, as prenatal therapy was recently shown to correct X-linked hypohidrotic ectodermal dysplasia (XLHED), a rare genetic disorder caused by a lack of sweat gland development due to a deficiency in ectodysplasin A (EDA). This evidence concerns the gene EDA and X-linked hypohidrotic ectodermal dysplasia.